Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis-Reference-Cited by-同舟云学术

Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis

Published:2017-07-19 Issue:8 Volume:13 Page:841-849
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Ovod Vitaliy¹,Ramsey Kara N.¹,Mawuenyega Kwasi G.¹,Bollinger Jim G.¹,Hicks Terry¹,Schneider Theresa¹,Sullivan Melissa¹,Paumier Katrina¹,Holtzman David M.¹²³,Morris John C.¹³,Benzinger Tammie³⁴,Fagan Anne M.¹²³,Patterson Bruce W.⁵,Bateman Randall J.¹²³

Affiliation:

1. Department of Neurology Washington University School of Medicine St. Louis MO USA

2. Department of Neurology, Hope Center for Neurological Disorders Washington University School of Medicine St. Louis MO USA

3. Department of Neurology Knight Alzheimer's Disease Research Center Washington University School of Medicine St. Louis MO USA

4. Department of Radiology Washington University School of Medicine St. Louis MO USA

5. Department of Medicine Washington University School of Medicine St. Louis MO USA

Funder

MetLife Foundation

AbbVie

Amgen

AstraZeneca

Biogen

Eisai

Pfizer

Sanofi

Avid Radiopharmaceuticals

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2017.06.2266

Reference17 articles.

1. The amyloid hypothesis of Alzheimer's disease at 25 years

2. Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers

3. Age and amyloid effects on human central nervous system amyloid-beta kinetics

4. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer's disease Centers, 2005‐2010;Beach TG;J Neuropathol Exp Neurol,2013

5. Early detection of Alzheimer's disease using PiB and FDG PET;Cohen AD;Neurobiol Dis,2014

Cited by 437 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disposable Pipette Extraction Followed by Direct MS/MS Analysis of Beta Amyloid Peptides (Aβ38, Aβ40, and Aβ42) in Cerebrospinal Fluid Samples;Journal of the Brazilian Chemical Society;2025

2. An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis;Journal of Pharmaceutical and Biomedical Analysis;2024-11

3. Navigating the Landscape of Plasma Biomarkers in Alzheimer's Disease: Focus on Past, Present, and Future Clinical Applications;Neurology and Therapy;2024-09-07

4. A streamlined, resource-efficient immunoprecipitation-mass spectrometry method for quantifying plasma amyloid-β biomarkers in Alzheimer's disease;2024-09-02

5. Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment;JAMA Neurology;2024-09-01